Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration)

NCT03591133 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: TS-143
DRUG: Placebo

Sponsor

Taisho Pharmaceutical Co., Ltd.